Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Significance: Dilated cardiomyopathy (DCM) is a progressive heart disease with no current cure, often culminating in heart transplantation. Transgenic D94A (aspartic acid-to-alanine) mice carrying a novel DCM-causative mutation in the MYL2 gene, encoding the cardiac myosin regulatory light chain, were created and investigated by echocardiography and invasive hemodynamic and molecular structural and functional assessments. Our data show that hypocontractile myosin motors and structural perturbations at the level of sarcomeres trigger aberrant functional remodeling in D94A hearts and the development of DCM, which closely follows the clinical phenotype. Left ventricular chamber dilation and decreased ejection fraction, observed in D94A hearts, were indicative of systolic dysfunction, a hallmark of DCM. Our study suggests that MYL2 may be considered a therapeutic target for dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2. (A) Hearts of representative ∼5-mo-old male and female D94A mice and their longitudinal sections showing biventricular cardiac dilation compared with respective WT controls. (Scale bars, 1 mm.) (B) Transmission electron microscopy images of ∼9-mo-old D94A-L1 vs. WT hearts. [Scale bars, 10 µm (Left), 2 µm (Middle), and 1 µm (Right).] Note excessive vacuolar formations in the myocardium of D94A vs. WT mice. (C) Hematoxylin and eosin- and Masson’s trichrome-stained LV sections from ∼5- and ∼12-mo-old M and F D94A-L1 and -L2 vs. WT mice. (Scale bar, 100 µm.) (D) Hydroxyproline content in the hearts of 7- to 11-mo-old M and F D94A-L1 and -L2 compared with WT mice.](https://figures.cochat.ai/paper-figures/0f36c6044a5c4719ac2377c5312b40c4/sarcomeric-perturbations-of-myosin-motors-lead-to-dilated-cardiomyopathy-in-figure-2.jpg)

![Fig. 4. (A) Contractile function in papillary muscle fibers from ∼5- and ∼12-mo-old D94A-L1 and -L2 vs. WT mice. Open symbols depict female and closed symbols indicate male animals. (B) The effect of D94A mutation on force and calcium transients in intact papillary muscles. The measurements were performed on intact papillary muscles from 6- to 8-mo-old gender-matched D94A-L1 (five M and three F) and WT (three M and three F) mice. Time (in milliseconds) to depart 50% (t50) from t0 to peak during contraction, and from peak to baseline during relaxation, is characterized by TF-contract and TF-relax (force transients) and TC-contract and TC-relax ([Ca2+] transients). Maximum velocity of force departing from and returning to the baseline during muscle contraction and relaxation is reported as VF-contract and VF-relax (force transients) and VC-contract and VC-relax ([Ca2+] transients). Note a significant (*P < 0.05) decrease in TF-relax in D94A-L1 vs. WT fibers. Results are presented as the average ± SD of n animals with *P < 0.05 and **P ≤ 0.01 for mutant vs. WT and #P < 0.05 for D94A-L1 vs. D94A-L2, using one-way ANOVA (A) or Student’s t test (B). (C) Gene expression profiles in D94A and WT mice. Real-time qPCR was performed on three F (open symbols) and three M (close symbols) D94A-L1 and WT mice, and the results are presented as fold change in transcript expression in D94A vs. WT mice. Data are the mean ± SEM. *P < 0.05, using one-way ANOVA with the Tukey’s multiple comparison test.](https://figures.cochat.ai/paper-figures/f064e9f4eaf443b58e202fbbaebac11d/sarcomeric-perturbations-of-myosin-motors-lead-to-dilated-cardiomyopathy-in-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Additionally, alternative splicing of sarcomere genes gives rise to variants that also exhibit distinct functionality (18–20).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics
Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,500
Pinto, Y. M., Elliott, P. M., Arbustini, E., Adler, Y., Anastasakis, A., Böhm, M., Duboc, D., Gimeno, J., de Groote, P., Imazio, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv727 · Cited by 1,099
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.105 · Cited by 1,025
Arber, S., Hunter, J. J., Ross, J., Hongo, M., Sansig, G., Borg, J., Perriard, J.-C., Chien, K. R., & Caroni, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81878-4 · Cited by 838
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz-Zagrosek, V., & Kararigas, G. (2017) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 732
Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., & Seidman, C. E. (2003) · Science · doi:10.1126/science.1081578 · Cited by 619
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Malik, F. I., Hartman, J. J., Elias, K. A., Morgan, B. P., Rodriguez, H., Brejc, K., Anderson, R. L., Sueoka, S. H., Lee, K. H., Finer, J. T., et al. (2011) · Science · doi:10.1126/science.1200113 · Cited by 584
Animal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Ventricular–Vascular Interaction in Heart Failure
Borlaug, B. A., & Kass, D. A. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.10.001 · Cited by 315
Cited by
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Metadata
- Authors
- Yuan, C.-C., Kazmierczak, K., Liang, J., Zhou, Z., Yadav, S., Gomes, A. V., Irving, T. C., & Szczesna-Cordary, D.
- Affiliations
- University of Miami (US)
- Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136;
- University of California, Davis (US)
- Illinois Institute of Technology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-02-20
- Volume
- 115
- Issue
- 10
- Pages
- E2338-E2347
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5877945
- OpenAlex
- W2793586929
- Cited by
- 36
- References
- 38
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 6 · 2018: 2
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | NIH | National Heart, Lung, and Blood Institute (HL123255, HL096819)
- HHS | NIH | National Institute of General Medical Sciences (9P41-GM103622)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- dilated cardiomyopathy, myosin light chain 2, systolic dysfunction, left ventricular dilatation, ejection fraction, transgenic mouse model, cardiac remodeling, therapeutic target
- MeSH terms
- Animals, Cardiomyopathy, Dilated, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Myocardial Contraction, Sarcomeres, Myosin Light Chains, Mutation, Missense, Myocytes, Cardiac, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice. https://app.cochat.ai/papers/10.1073/pnas.1716925115
- The paper
- Yuan, C.-C., Kazmierczak, K., Liang, J., Zhou, Z., Yadav, S., Gomes, A. V., Irving, T. C., & Szczesna-Cordary, D. (2018). Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1716925115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.